Sobi seeks an Associate Director for RDMA Strategy and Portfolio in Basel to lead strategic planning, digital roadmaps, and governance insights for rare disease treatments.
This role serves as a strategic thought partner to senior RDMA leadership, owning the development and continuous evolution of the RDMA strategy and portfolio insights. The position is central to shaping portfolio-level decisions, advancing digital and AI-enabled capabilities, and strengthening governance frameworks to support high-impact decision-making.
Responsibilities
- Collaborate with the Head of RDMA S&O to define and implement the overall RDMA strategy.
- Lead the definition and execution of the RDMA digital and AI roadmap.
- Shape and continuously improve the RDMA operating model, governance structures, and decision processes.
- Translate portfolio data into clear, decision-ready insights for RDMA LT, ExCom, and Portfolio Review Committees.
- Act as the RDMA strategy lead in BD scouting and due diligence, ensuring consistency, comparability, and strategic fit.
- Drive preparation of high-impact materials for senior governance forums.
Requirements
- Experience in portfolio management, R&D strategy, or enterprise-level analytics within Pharma/Biotech.
- Proven ability to synthesize complex data into executive-level insights and recommendations.
- Experience working with senior governance bodies (LT, ExCom, Portfolio Committees).
- Life Science MSc or completed Medicine degree.
- Professional proficiency in English.
Nice to have
- Exposure to BD, due diligence, or asset evaluation strongly preferred.
- Familiarity with R&D digital tools, portfolio systems, or analytics platforms is an advantage.
What the company offers
- Competitive compensation for your work.
- Emphasis on work/life balance.
- Collaborative and team-oriented environment.
- Opportunities for professional growth.
- Diversity and Inclusion.
- Making a positive impact to help ultra-rare disease patients who are in need of life saving treatments.
About the company
Sobi is a specialized biopharmaceutical company dedicated to rare diseases. The company refuses to accept the status quo and operates as a global entity with over 1,900 employees in more than 30 countries, committed to the societies where it operates.
- Refusing to accept the status quo.
- Dedication to rare diseases.
- Global presence with over 1,900 employees in more than 30 countries.
- Commitment to the societies where the company operates.
How to apply
Documents to submit:
Application language: English
Quelle: öffentlich zugängliche Karriereseite des Arbeitgebers. Batchly ist nicht der Arbeitgeber und steht nicht notwendigerweise in einem Vertragsverhältnis mit dem Unternehmen.